

CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Human Peptide Hormone
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Cagrilintide is a synthetic analog of the natural hormone amylin, developed to help control appetite and support long-term weight reduction. Manufactured by Peptide Hubs, this injectable peptide comes in a 2 mL vial containing 10 mg of high-purity Cagrilintide Acetate, suitable for research focused on metabolic health and satiety regulation.
Cagrilintide works by mimicking amylin, a hormone co-secreted with insulin, which acts on the brain to reduce food intake and delay gastric emptying. It enhances satiety signals, helping users feel fuller for longer periods. As highlighted in a 2022 study published on PubMed, Cagrilintide has shown promising results in clinical trials when used alongside GLP-1 receptor agonists like Semaglutide for obesity treatment.
Many users exploring metabolic enhancement combine Cagrilintide with Semaglutide or AOD 9604 to accelerate fat loss while managing appetite more effectively.
The typical research protocol involves dosing between 0.1 mg to 0.3 mg daily, via subcutaneous injection. Research has shown that results may take several weeks to manifest, and consistent use over 8–12 weeks is common in studies. To further support metabolic outcomes, researchers may stack it with Ipamorelin or CJC-1295 DAC.
This premium-grade compound is offered by a reputable supplier specializing in advanced peptides for body composition and metabolic research. No lab test is currently published, but it is manufactured under strict quality protocols to ensure consistency and purity.
Cagrilintide is used in research settings to explore its effects on appetite suppression, satiety regulation, and long-term weight loss support. It mimics the natural hormone amylin.
Cagrilintide binds to amylin receptors in the brain, promoting feelings of fullness and reducing gastric emptying. This leads to decreased calorie intake and improved weight control.
Typical research dosages range from 0.1 mg to 0.3 mg daily via subcutaneous injection. Research protocols often extend over 8–12 weeks to observe metabolic changes.
Yes, researchers often stack Cagrilintide with Semaglutide, AOD 9604, or Ipamorelin to amplify weight loss and hormonal synergy in metabolic studies.
Yes, Cagrilintide is legal for research purposes in the USA and is available through trusted sources like Peptide Hubs.
Please log in to write Cagrilintide 10 mg review.
CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Stealth Labs USA
Tested in Laboratory: View Lab Report
Shipped Without Label!
IPAMORELIN 5 MG INJECTION
Drug Class: Injectable
Composition:
- Active Substance: Ipamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
THYMOSIN BETA 4 5 MG INJECTION
Drug Class: Human Peptide Hormone
Composition:
- Active Substance: Thymosin Beta 4
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
THYMOSIN BETA 4, PENTADECAPEPTIDE 10 MG INJECTION
Drug Class: Dual Healing Peptide
Composition:
- Active Substance: Thymosin Beta 4 (5 mg), Pentadecapeptide (5 mg)
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report